Varenicline Tablet, Film Coated
Product Images NDC 70710-1614

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Varenicline (NDC 70710-1614). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (625ba12e C50b 4711 8ac1 3d4157519f52 01)

Image (625ba12e C50b 4711 8ac1 3d4157519f52 01)
Chemical structure of Varenicline showing its molecular configuration with distinct functional groups and ring systems.*
FDA Label Image

Image (625ba12e C50b 4711 8ac1 3d4157519f52 02)

Image (625ba12e C50b 4711 8ac1 3d4157519f52 02)
A bar graph comparing the percentage outcomes of various treatments including Varenicline 0.5 mg BID, Varenicline 1 mg BID, Varenicline Flexible, Bupropion SR 150 mg BID, and Placebo across four different studies labeled STUDY 2, STUDY 3, STUDY 4, and STUDY 5. Each study group shows different height bars with error bars indicating variability.*
FDA Label Image

Image (625ba12e C50b 4711 8ac1 3d4157519f52 03)

Image (625ba12e C50b 4711 8ac1 3d4157519f52 03)
A bar chart comparing percentage values across multiple studies (Study 2 to Study 5) for Varenicline at 0.5 mg BID, Varenicline 1 mg BID, placebo, Varenicline Flexible, Bupropion SR 150 mg BID, and placebo groups. Error bars are shown for each data point indicating variability or confidence intervals.*
FDA Label Image

Image (625ba12e C50b 4711 8ac1 3d4157519f52 04)

Image (625ba12e C50b 4711 8ac1 3d4157519f52 04)
A line graph depicting the percentage of continuous abstinent individuals over nontreatment follow-up weeks, comparing Varenicline 1 mg BID versus placebo. The x-axis represents weeks of nontreatment follow-up, and the y-axis shows the percentage of continuous abstinence. Two lines show a decline in abstinence percentage over time, with Varenicline consistently higher than placebo.*
FDA Label Image

0.5 mg (625ba12e C50b 4711 8ac1 3d4157519f52 05)

0.5 mg (625ba12e C50b 4711 8ac1 3d4157519f52 05)
Label for Varenicline Tablets 0.5 mg by Zydus Pharmaceuticals USA Inc. The film-coated oral tablets come in a package of 56 tablets for prescription use only. The label includes dosage details, storage instructions, and manufacturer and distributor information.*
FDA Label Image

1 mg (625ba12e C50b 4711 8ac1 3d4157519f52 06)

1 mg (625ba12e C50b 4711 8ac1 3d4157519f52 06)
Varenicline Tablets 1 mg film-coated tablets packaging label. The label shows the product name, strength, dosage form, quantity of 56 tablets, Rx only status, and labeler Zydus Pharmaceuticals USA Inc. Additional text includes dosage information, storage instructions, and contact details for medication guide availability. The label includes a barcode and NDC 70710-1614-6.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.